Site Search

Search
Showing 1 - 8 of 8 results
About the CF Foundation | Clinical Trials | Our Research Approach
CF Foundation Awards Up to $5 Million to BiomX for Potential Phage Therapy

Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance

Press Release |
| 4 min read
Clinical Trials
First-of-Its-Kind Study Uses Smartphone to Track Cystic Fibrosis in Real Life

Observational study supported by the CF Foundation will monitor real-world experience with Trikafta

Press Release |
| 4 min read
Research | About the CF Foundation | Clinical Trials
CF Foundation Awards Up to $2M to Eloxx for Additional Support for Studies into Nonsense Mutations Therapy

Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.

Press Release |
| 4 min read
Clinical Trials | Our Research Approach
CF Foundation Funds Expansion of Clinical Trial Program for Potential Nonsense Mutations Therapy

The Cystic Fibrosis Foundation is awarding up to $15.9 million in additional funding to Eloxx Pharmaceuticals Inc. to expand clinical studies of ELX-02, a potential therapy for people with CF who have nonsense mutations.

Press Release |
| 4 min read